Dr. Robert Parker, MD
- Part D claims, 2017
- 12
- Publications
- 40
- Clinical trials
- 17
- Industry payments
- $20
- State licenses
- 2
- Practice address
- Hsc T 11, Stony Brook, NY 11794-8111
- Practice phone
- Call (631) 444-7720
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Find Dr. Parker's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Robert Parker is a pediatric hematology and oncology physician in Stony Brook, New York
Dr. Parker practices in Stony Brook, New York.
Dr. Parker's NPI, 1902849714, was assigned on June 13, 2006. Dr. Parker graduated from The Warren Alpert Medical School of Brown University in 1976. Dr. Parker's New York license number on file is 186763.
- NPI
- 1902849714NPI Registry (opens in a new tab)
- NPI enumeration date
- June 13, 2006
- NPI status
- Active
- Practice phone
- (631) 444-7720
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Medical school graduation
- 1976
Sources: NPPES NPI Registry (CMS); and Dmand AI Professional Profile Data
Dr. Robert Parker's practice address is in Stony Brook, New York
Dr. Parker's practice address in the NPI Registry is Hsc T 11, Stony Brook, NY 11794-8111. The practice phone is (631) 444-7720.
- NPI Registry addressHsc T 11, Stony Brook, NY 11794-8111Phone(631) 444-7720
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dmand AI tracks the EHR system at Dr. Robert Parker's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Parker practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Dr. Parker's practice | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Robert Parker is one of 232 pediatric hematologys and oncology physicians in New York
Pediatric hematology-oncology is Dr. Parker's primary specialty in the NPI Registry, under taxonomy code 2080P0207X. Dr. Parker is board certified in pediatric hematology-oncology by the American Board of Pediatrics. Dmand AI has Dr. Parker's licenses on file in 2 states: New York and Maryland.
Specialties and state licenses
- Pediatric hematology and oncology, New YorkPrimary
- Maryland license
Pediatric hematologys and oncology physicians near Dr. Parker
Counts of pediatric hematologys and oncology physicians with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Robert Parker wrote 12 Medicare Part D claims in 2017
In 2017, Dr. Parker wrote 12 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $387 in total drug cost. In 2016, CMS named 12 claims across 1 drug.
Dr. Parker's most prescribed drugs by claims, 2017
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2016 to 2017
- 2016
- 2017
- Claims for drugs CMS names
- 2016: 122017: 12No change
Drugs named by CMS: 1 in 2017, 1 in 2016.
Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Robert Parker has 40 publications on record
Dmand AI links 40 papers to Dr. Parker, published from 2014 to 2021. 2020 was the busiest year, with 4. The most frequent topics are Critical Illness, Erythrocyte Transfusion and Critical Care. Dr. Parker has published most often in Pediatr Crit Care Med. Dr. Parker's most frequent co-authors are Marianne Nellis, MD, Marie Elizabeth Steiner, MD and Adam Mark Vogel, MD.
Dr. Parker's papers by year, 2014 to 2021
Topics Dr. Parker writes about most
- Critical Illness
- Erythrocyte Transfusion
- Critical Care
- Evidence-Based Medicine
- Hemorrhage
- Anemia
- Platelet Transfusion
- Blood Component Transfusion
Dr. Parker's most frequent co-authors
- Marianne Nellis, MD7 shared papers
- Marie Elizabeth Steiner, MD7 shared papers
- Adam Mark Vogel, MD7 shared papers
Recent publications by Dr. Parker
Magn Reson Imaging
See who Dr. Parker researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Parker works with, so you can find a warm path to the right pediatric hematologys and oncology physicians.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Robert Parker has worked on 17 clinical trials
Dmand AI links Dr. Parker to 17 clinical trials, 8 of them phase 3 studies. 12 are still active or recruiting. Conditions studied include Burkitt Lymphoma, Epstein-Barr Virus Infections and Precursor Cell Lymphoblastic Leukemia-Lymphoma. Children's Oncology Group sponsors the most, 11.
Conditions in Dr. Parker's trials
- Burkitt Lymphoma
- Epstein-Barr Virus Infections
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Angiolipoma
- Askin Tumor
Investigators on the most trials with Dr. Parker
- Judy Linn Felgenhauer, MD13 shared trials
- Carl Lenarsky, MD13 shared trials
- Leo Mascarenhas, MD13 shared trials
Recent clinical trials with Dr. Parker
Risk-Stratified Randomized Phase III Testing of Blinatumomab (NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL) (opens in a new tab)
Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB, Stage IIIB, IVA, or IVB Hodgkin Lymphoma (opens in a new tab)
Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma (opens in a new tab)
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Robert Parker received $20 in industry payments in 2018
CMS Open Payments shows 1 general payment to Dr. Parker from 1 drug or device company in 2018. Food and beverage make up the largest share, 100% of the total. Silvergate Pharmaceuticals, Inc. paid the most, $20.
Companies that paid Dr. Parker the most, 2018 to 2018
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Robert Parker has 2 awards and honors on record
Dmand AI lists 2 awards for Dr. Parker, most recently Lane Adams Award in 2008.
Awards and honors for Dr. Parker
- 2008
- Lane Adams Award
- Undated
- Checkbook Top Doc
Source: Dmand AI Professional Profile Data
Dr. Robert Parker graduated from The Warren Alpert Medical School of Brown University
Dr. Parker graduated from The Warren Alpert Medical School of Brown University in 1976. Dr. Parker is a member of AOA, AAP, American Pediatric Society, ASH, American Society of Pediatric Hematology/Oncology and International Society on Thrombosis and Haemostasis.
- Medical school
- Board certified in pediatric hematology-oncology
- Board certified in pediatrics
Source: Dmand AI Professional Profile Data
Sources for Dr. Robert Parker's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Robert Parker
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Robert Parker's NPI number?
Dr. Robert Parker's NPI number is 1902849714. It was assigned on June 13, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Robert Parker?
Dr. Robert Parker is a pediatric hematology and oncology physician in Stony Brook, New York. The primary specialty in the NPI Registry is Pediatric Hematology & Oncology Physician (taxonomy code 2080P0207X).
Where does Dr. Robert Parker practice?
Dr. Parker practices at Hsc T 11, Stony Brook, NY 11794-8111.
What is Dr. Robert Parker's office phone number?
The practice phone on file for Dr. Parker is (631) 444-7720.
What is Dr. Robert Parker's medical license number?
Dr. Parker's New York license number on file is 186763, one of the licenses on file in 2 states.
Which states has Dr. Robert Parker been licensed in?
Dmand AI has state licenses on file for Dr. Parker in New York (1991 to 2020) and Maryland (1982 to 1991).
Is Dr. Robert Parker board certified?
Yes. Dr. Parker is board certified in pediatric hematology-oncology by the American Board of Pediatrics.
Where did Dr. Robert Parker go to medical school?
Dr. Parker graduated from The Warren Alpert Medical School of Brown University in 1976.
What drugs does Dr. Robert Parker prescribe most?
In 2017 Medicare Part D data, Dr. Parker's most prescribed drugs by claims were Azathioprine.
Has Dr. Robert Parker received payments from drug or device companies?
CMS Open Payments shows $20 in general payments to Dr. Parker from 1 company from 2018 to 2018. The largest total came from Silvergate Pharmaceuticals, Inc.
Show 3 more questionsShow fewer questions
How long has Dr. Robert Parker been practicing?
Dr. Parker graduated from medical school in 1976, 50 years ago.
Does Dr. Robert Parker do research?
Dmand AI links 40 publications to Dr. Parker, published from 2014 to 2021. Dr. Parker has worked on 17 clinical trials.
Who does Dr. Robert Parker publish with?
Dr. Parker's most frequent co-authors are Marianne Nellis, MD (7 shared papers), Marie Elizabeth Steiner, MD (7 shared papers) and Adam Mark Vogel, MD (7 shared papers).
Selling to pediatric hematology-oncology practices?
See pediatric hematologys and oncology physicians in New York by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card